Nplate News
Most Popular Nplate Story
FDA approves Amgen's Nplate
Amgen has received FDA approval for Nplate for the treatment of immune thrombocytopenic purpura (ITP). ITP is a bleeding condition--which affects about 60,000 people in the U.S.-- that causes the Read more...
Latest Headlines
- August 25, 2008
- July 22, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
